Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ODAC does not recommend approval of oxaliplatin combination therapy

March 20, 2000

NeoPharm receives milestone payment from P&U for LEP

March 20, 2000

Decitabine effective in myelodysplastic syndrome

March 20, 2000

Anticancer activity, pharmacokinetics and safety of E-7869

March 17, 2000

Anti-VEGF antisense oligonucleotides in the Aventis pipeline

March 17, 2000

ImClone achieves milestone in IMC-C225 agreement with Merck KGaA

March 17, 2000

sNDA for Nolvadex in DCIS to undergo priority review

March 17, 2000

EGF receptor tyrosine kinase inhibitor selected for clinical testing at Parke-Davis

March 16, 2000

NIH advisory committee approves phase III protocol for Introgen's p53 gene therapy

March 15, 2000

Orphan Medical's Busulfex approved in Israel

March 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...